Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego , 9500 Gilman Drive MC0684, La Jolla, California 92093, United States.
Department of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, and Bijvoet Center for Biomolecular Research, Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
J Am Chem Soc. 2017 Jul 19;139(28):9534-9543. doi: 10.1021/jacs.7b01399. Epub 2017 Jul 7.
Heparan sulfates (HS) are linear sulfated polysaccharides that modulate a wide range of physiological and disease-processes. Variations in HS epimerization and sulfation provide enormous structural diversity, which is believed to underpin protein binding and regulatory properties. The ligand requirements of HS-binding proteins have, however, been defined in only a few cases. We describe here a synthetic methodology that can rapidly provide a library of well-defined HS oligosaccharides. It is based on the use of modular disaccharides to assemble several selectively protected tetrasaccharides that were subjected to selective chemical modifications such as regioselective O- and N-sulfation and selective de-sulfation. A number of the resulting compounds were subjected to enzymatic modifications by 3-O-sulfotransferases-1 (3-OST1) to provide 3-O-sulfated derivatives. The various approaches for diversification allowed one tetrasaccharide to be converted into 12 differently sulfated derivatives. By employing tetrasaccharides with different backbone compositions, a library of 47 HS-oligosaccharides was prepared and the resulting compounds were used to construct a HS microarray. The ligand requirements of a number of HS-binding proteins including fibroblast growth factor 2 (FGF-2), and the chemokines CCL2, CCL5, CCL7, CCL13, CXCL8, and CXCL10 were examined using the array. Although all proteins recognized multiple compounds, they exhibited clear differences in structure-binding characteristics. The HS microarray data guided the selection of compounds that could interfere in biological processes such as cell proliferation. Although the library does not cover the entire chemical space of HS-tetrasaccharides, the binding data support a notion that changes in cell surface HS composition can modulate protein function.
硫酸乙酰肝素(HS)是一种线性硫酸化多糖,可调节多种生理和疾病过程。HS 差向异构化和硫酸化的变化提供了巨大的结构多样性,据信这是蛋白质结合和调节特性的基础。然而,只有在少数情况下才定义了 HS 结合蛋白的配体要求。我们在这里描述了一种快速提供一系列定义明确的 HS 寡糖文库的合成方法。它基于使用模块化二糖来组装几个选择性保护的四糖,这些四糖经过选择性化学修饰,如区域选择性 O-和 N-硫酸化和选择性脱硫酸化。许多得到的化合物都经过 3-O-磺基转移酶-1(3-OST1)的酶修饰,以提供 3-O-硫酸化衍生物。各种多样化方法允许将一种四糖转化为 12 种不同硫酸化的衍生物。通过使用具有不同骨架组成的四糖,制备了 47 种 HS-寡糖文库,并将得到的化合物用于构建 HS 微阵列。使用该阵列研究了包括成纤维细胞生长因子 2(FGF-2)在内的一些 HS 结合蛋白以及趋化因子 CCL2、CCL5、CCL7、CCL13、CXCL8 和 CXCL10 的配体要求。尽管所有蛋白质都识别多种化合物,但它们在结构结合特征上表现出明显差异。HS 微阵列数据指导选择可以干扰细胞增殖等生物学过程的化合物。尽管该文库并未涵盖 HS-四糖的整个化学空间,但结合数据支持这样一种观点,即细胞表面 HS 组成的变化可以调节蛋白质功能。